CTLP vs DBD

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

CTLP

44.4
AI Score
VS
DBD Wins

DBD

59.7
AI Score

Investment Advisor Scores

CTLP

Aug 22, 2026
44score
Recommendation
HOLD

DBD

Aug 22, 2026
60score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CTLP DBD Winner
Forward P/E 25.4453 12.1655 DBD
PEG Ratio 8.6933 0 Tie
Revenue Growth 6.8% 1.7% CTLP
Earnings Growth 201.7% 34.2% CTLP
Tradestie Score 44.4/100 59.7/100 DBD
Profit Margin 17.3% 2.9% CTLP
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

CTLP 1M: +4.0% · 3M: +5.0% DBD 1M: -19.6% · 3M: -3.4%

Current Technical Phase

CTLP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 75

RSI (14): 75.4 · Price: $11.20

DBD

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.4%), weak momentum, RSI 39

RSI (14): 38.7 · Price: $69.94

Fundamentals Snapshot

Metric CTLP DBD
Market Cap
Forward P/E 21.5 10.0
Trailing P/E 15.3 22.3
Revenue (TTM)
Revenue Growth 0.1% 0.0%
Gross Margin 0.4% 0.3%
Operating Margin 0.1% 0.1%
EPS 0.73 3.04
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, DBD is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.